Source: Philadelphia Business Journal John George
Genomind, a King of Prussia, Pa., personalized medicine company, is getting some national exposure.
The company Genecept Assay — a genetic test designed to help clinicians make more informed treatment decisions for their patients with mental illness — will be featured on Tuesday’s episode of “Dr. Phil.” The cheek swab test analyzes key genes to determine which medicines are like to be the most effective for a person given their DNA makeup.
Dr. Phil McGraw, a psychologist and author, and his producers selected Genomind’s Genecept Assay to be highlighted as part of a program focused on helping a family in crisis.
The March 29 television program will tell the story of a girl struggling with a variety of mental health challenges who has tried numerous treatments without success. Dr. Phil and the girl’s treating psychiatrist will offer the Genecept Assay as a potential way to help reduce the time, expense and struggle of finding the right treatment by trial and error.
I last wrote about Genomind in February after the company raised $3.5 million in a private stock sale.
The Dr. Phil program airs on KYW 3 at 4 p.m.